Article Details

Canaccord Genuity Group Reaffirms Buy Rating for BioNTech (NASDAQ:BNTX)

Retrieved on: 2022-07-07 13:46:25

Tags for this article:

Click the tags to see associated articles and topics

Canaccord Genuity Group Reaffirms Buy Rating for BioNTech (NASDAQ:BNTX). View article details on HISWAI: https://www.defenseworld.net/2022/07/07/canaccord-genuity-group-reaffirms-buy-rating-for-biontech-nasdaqbntx.html

Excerpt

BNTX has been the topic of several other research reports. Deutsche Bank Rese… set a $180.00 price objective on shares of BioNTech in a research note ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up